{
    "organizations": [],
    "uuid": "b4b093b1437e8785b2e0c761ab744c5b461174d2",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-boya-bio-pharmaceutical-group-sub/brief-boya-bio-pharmaceutical-group-sub-subsidiary-receives-gmp-certificate-idUSL3N1R849Z",
    "ord_in_thread": 0,
    "title": "BRIEF-Boya Bio-pharmaceutical Group sub-subsidiary receives GMP certificate",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 26 (Reuters) - Boya Bio-pharmaceutical Group Co Ltd :\n* Says its sub-subsidiary received goods manufacture practice (GMP) certificate from Jiangxi Food and Drug Administration\n* Certificate issued calcium dobesilate manufactured by the unit and the valid period is until March 20, 2023\nSource text in Chinese: goo.gl/EspCbb\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-03-26T19:11:00.000+03:00",
    "crawled": "2018-03-27T12:14:48.073+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "boya",
        "group",
        "co",
        "ltd",
        "say",
        "received",
        "good",
        "manufacture",
        "practice",
        "gmp",
        "certificate",
        "jiangxi",
        "food",
        "drug",
        "administration",
        "certificate",
        "issued",
        "calcium",
        "dobesilate",
        "manufactured",
        "unit",
        "valid",
        "period",
        "march",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}